Lung cancer is one of the leading causes of death worldwide. There are 2 major subtypes of
lung cancer, non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) …

Chemotherapy and targeted therapy have significantly improved the progression of non-
small cell lung cancer (NSCLC), but patients are inevitably suffering from drug resistance …

Immunotherapy is one of the methods that can change the survival rate of patients with
malignant tumors, in addition to surgery therapy, radiotherapy, chemotherapy and targeted …

Lung cancer is the leading cause of cancer mortality and non-small cell lung cancer
(NSCLC) accounts for more than 85% of all lung cancers. Platinum-based doublet …

Lung cancer, with non-small cell lung cancer (NSCLC) being the major type, is the second
most common malignancy and the leading cause of cancer-related death globally …

The use of immune checkpoint inhibitors (ICIs) has become one of the most promising
approaches in the field of cancer therapy. Unlike the current therapies that target tumor cells …

Non-small cell lung cancer (NSCLC) has been threatening human health for years.
Cytotoxicity-based chemotherapy seems to reach plateau in NSCLC treatment …

Introduction. Immunotherapy has become an increasingly important therapeutic strategy for
those with cancer, with phase III studies demonstrating survival advantages in melanoma …

Historically, non-small-cell lung cancer (NSCLC) has been regarded as a nonimmunogenic
tumor; however, recent studies have shown that NSCLCs are among the most responsive …

Lung cancer is the leading cause of cancer-related death worldwide. Treatment of non-small
cell lung cancer has evolved tremendously over the past decade. Specifically, immune …